Literature DB >> 20638059

Aromatase inhibitors in women with clomiphene citrate resistance: a randomized, double-blind, placebo-controlled trial.

Mohan S Kamath1, T K Aleyamma, Achamma Chandy, Korula George.   

Abstract

In 36 women with polycystic ovary syndrome and clomiphene citrate resistance, letrozole, an aromatase inhibitor, statistically significantly increased the ovulation rate by 33.3% in the treatment group, indicating that letrozole can be used as an effective and simple alternate ovulation-inducing agent in these women.
Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20638059     DOI： 10.1016/j.fertnstert.2010.06.008

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  10 in total

Review 1.  Clinical review: The use of aromatase inhibitors for ovulation induction and superovulation.

Authors:  Mary Ellen Pavone; Serdar E Bulun
Journal:  J Clin Endocrinol Metab       Date:  2013-04-12       Impact factor: 5.958

2.  Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and age.

Authors:  Z Desta; Y Kreutz; A T Nguyen; L Li; T Skaar; L K Kamdem; N L Henry; D F Hayes; A M Storniolo; V Stearns; E Hoffmann; R F Tyndale; D A Flockhart
Journal:  Clin Pharmacol Ther       Date:  2011-10-05       Impact factor: 6.875

Review 3.  Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.

Authors:  Sebastian Franik; Quang-Khoi Le; Jan Am Kremer; Ludwig Kiesel; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2022-09-27

4.  Emulating a target trial of the comparative effectiveness of clomiphene citrate and letrozole for ovulation induction.

Authors:  Jennifer J Yland; Yu-Han Chiu; Paolo Rinaudo; John Hsu; Miguel A Hernán; Sonia Hernández-Díaz
Journal:  Hum Reprod       Date:  2022-04-01       Impact factor: 6.918

5.  Letrozole or clomiphene citrate as first line for anovulatory infertility: a debate.

Authors:  Mohan S Kamath; Korula George
Journal:  Reprod Biol Endocrinol       Date:  2011-06-21       Impact factor: 5.211

Review 6.  Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.

Authors:  Sebastian Franik; Stephanie M Eltrop; Jan Am Kremer; Ludwig Kiesel; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2018-05-24

7.  Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility.

Authors:  M F Costello; M L Misso; A Balen; J Boyle; L Devoto; R M Garad; R Hart; L Johnson; C Jordan; R S Legro; R J Norman; E Mocanu; J Qiao; R J Rodgers; L Rombauts; E C Tassone; S Thangaratinam; E Vanky; H J Teede
Journal:  Hum Reprod Open       Date:  2019-01-04

Review 8.  A Review of First Line Infertility Treatments and Supporting Evidence in Women with Polycystic Ovary Syndrome.

Authors:  Michael Costello; Rhonda Garad; Roger Hart; Hayden Homer; Louise Johnson; Cailin Jordan; Edgar Mocanu; Jie Qiao; Luk Rombauts; Helena J Teede; Eszter Vanky; Christos Venetis; William Ledger
Journal:  Med Sci (Basel)       Date:  2019-09-10

9.  A Randomized Clinical Trial on Comparing The Cycle Characteristics of Two Different Initiation Days of Letrozole Treatment in Clomiphene Citrate Resistant PCOS Patients in IUI Cycles.

Authors:  Nayereh Ghomian; Ashraf Khosravi; Nezhat Mousavifar
Journal:  Int J Fertil Steril       Date:  2015-04-21

Review 10.  Current evidence supporting "letrozole" for ovulation induction.

Authors:  Sujata Kar
Journal:  J Hum Reprod Sci       Date:  2013-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.